Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Lottenberg

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
American Journal of Preventive Medicine|March 25, 2010
Nonmalignant blood disorders: time to establish a public health agendaRichard Lottenberg
Southern Medical Journal|December 17, 2008
Cocaine abuse complicating acute painful episodes in sickle cell diseaseBrian Boulmay, Richard Lottenberg
Inflammation & Allergy Drug Targets|October 5, 2010
Bacterial adaptation and infectionMichael D Boyle, Richard Lottenberg
Microbiology (Reading, England)|August 28, 1998
Site-directed mutagenesis of streptococcal plasmin receptor protein (Plr) identifies the C-terminal Lys334 as essential for plasmin binding, but mutation of the plr gene does not reduce plasmin binding to group A streptococciScott B Winram, Richard Lottenberg
Hematology. American Society of Hematology. Education Program|November 24, 2005
An evidence-based approach to the treatment of adults with sickle cell diseaseRichard Lottenberg, Kathryn L Hassell
The American Journal of Emergency Medicine|September 27, 2014
Approach to the diagnosis and treatment of acute subarachnoid hemorrhage in a patient with sickle cell diseaseMatthew Lyon, Justin Jeter, Richard Lottenberg
American Journal of Hematology|May 16, 2003
Role of phlebotomy in the management of hemoglobin SC disease: case report and review of the literatureMerry Jennifer Markham, Richard Lottenberg, Marc Zumberg
Journal of Thrombosis and Thrombolysis|May 27, 2009
Thrombotic storm in Kimura diseaseHong Liu, Samer Z Al-Quran, Richard Lottenberg
Journal of Thrombosis and Thrombolysis|January 16, 2007
Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safeCraig S Kitchens, Molly H Weidner, Richard Lottenberg
The American Journal of the Medical Sciences|February 21, 2014
Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemiaMartina Murphy, Julia Close, Richard Lottenberg, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
American Journal of Preventive Medicine|March 25, 2010
Nonmalignant blood disorders: time to establish a public health agendaRichard Lottenberg
Southern Medical Journal|December 17, 2008
Cocaine abuse complicating acute painful episodes in sickle cell diseaseBrian Boulmay, Richard Lottenberg
Inflammation & Allergy Drug Targets|October 5, 2010
Bacterial adaptation and infectionMichael D Boyle, Richard Lottenberg
Microbiology (Reading, England)|August 28, 1998
Site-directed mutagenesis of streptococcal plasmin receptor protein (Plr) identifies the C-terminal Lys334 as essential for plasmin binding, but mutation of the plr gene does not reduce plasmin binding to group A streptococciScott B Winram, Richard Lottenberg
Hematology. American Society of Hematology. Education Program|November 24, 2005
An evidence-based approach to the treatment of adults with sickle cell diseaseRichard Lottenberg, Kathryn L Hassell
The American Journal of Emergency Medicine|September 27, 2014
Approach to the diagnosis and treatment of acute subarachnoid hemorrhage in a patient with sickle cell diseaseMatthew Lyon, Justin Jeter, Richard Lottenberg
American Journal of Hematology|May 16, 2003
Role of phlebotomy in the management of hemoglobin SC disease: case report and review of the literatureMerry Jennifer Markham, Richard Lottenberg, Marc Zumberg
Journal of Thrombosis and Thrombolysis|May 27, 2009
Thrombotic storm in Kimura diseaseHong Liu, Samer Z Al-Quran, Richard Lottenberg
Journal of Thrombosis and Thrombolysis|January 16, 2007
Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safeCraig S Kitchens, Molly H Weidner, Richard Lottenberg
The American Journal of the Medical Sciences|February 21, 2014
Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemiaMartina Murphy, Julia Close, Richard Lottenberg, et al.
Pageof 4